[Antiviral therapy and risk for hepatocellular carcinoma in chronic viral hepatitis].
Hepatocellular carcinoma (HCC) is one of the most common human malignancies in incidence and mortality, which develops in the majority of patients in the stage of cirrhosis. Because of the major etiological role of hepatitis viruses, the prevention of HCC is vaccination against hepatitis B virus and successful antiviral therapy for chronic hepatitis B and C.
D T
DT
Abdurakhmanov
D000998:Antiviral Agents / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000453:epidemiology* / Q000209:etiology; D014943:Global Health; D006521:Hepatitis, Chronic / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology; D006525:Hepatitis, Viral, Human / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D008113:Liver Neoplasms / Q000453:epidemiology* / Q000209:etiology; D012307:Risk Factors; D015996:Survival Rate / Q000639:trends
D000998:Antiviral Agents